Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data-Reference-Cited by-同舟云学术

Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data

Published:2016-06 Issue:3 Volume:31 Page:224-233
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Gaohua Lu,Neuhoff Sibylle,Johnson Trevor N.,Rostami-Hodjegan Amin,Jamei Masoud

Funder

Simcyp Limited

European Commission

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference58 articles.

1. Impact of physiologically-based pharmacokinetic modelling and simulation in drug development;Shardlow;Drug Metab Dispos,2013

2. Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicin;Varma;Drug Metab Dispos,2013

3. From preclinical to human–prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example;Sinha;Biopharm Drug Dispos,2012

4. Impact of low-dose ritonavir on danoprevir pharmacokinetics: results of computer-based simulations and a clinical drug-drug interaction study;Reddy;Clin Pharmacokinet,2012

5. Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions;Varma;Pharm Res,2012

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly?;2024-08-14

2. Proteomic Profiling Reveals Age-Related Changes in Transporter Proteins in the Human Blood-Brain Barrier;2024-07-27

3. Pharmacokinetic Modeling of the Effect of Tariquidar on Ondansetron Disposition into the Central Nervous System;Pharmaceutical Research;2024-07

4. CNS Viral Infections—What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches;CNS Drugs;2024-04-05

5. Predictions of Bedaquiline Central Nervous System Exposure in Patients with Tuberculosis Meningitis Using Physiologically based Pharmacokinetic Modeling;Clinical Pharmacokinetics;2024-03-26